This is BrainsWay’s global website. The website includes information on clinical indications that were not cleared by the FDA and are considered investigational by the U.S. medical device regulations. BrainsWay D treatment is FDA cleared for patients with MDD who failed to respond to one or more anti-depressants in the current episode.
Mr. Hagai is a businessman who serves as director of several private and public companies.
He served as Chairman of the Board of public companies and has extensive business experience and expertise in various fields.